{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:28:52Z","timestamp":1770812932685,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Shaoxing Industrial R&D Program","award":["2022B43006"],"award-info":[{"award-number":["2022B43006"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2019YFA0905400"],"award-info":[{"award-number":["2019YFA0905400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Laboratory of Lead Druggability Research","award":["NKLKF2023003"],"award-info":[{"award-number":["NKLKF2023003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antibiotic resistance and tolerance pose dual challenges to clinical antibiotic therapy, with tolerance potentially accelerating resistance evolution. LYSC98, a candidate drug that has just received clinical approval in China, has been reported to have bactericidal activity against antibiotic-resistant Staphylococcus aureus. However, its mechanism and activity against antibiotic-resistant bacteria in tolerant state remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the antibacterial activity of LYSC98 against antibiotic-resistant bacteria in different metabolite states, and to elucidate its mechanism of action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>MIC values of antimicrobial agents were determined using broth microdilution. Time\u2013kill assays were used to evaluate the bactericidal effect. SEM and TEM were conducted to visualize the morphological changes. Membrane permeability was determined by propidium iodide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LYSC98 showed potent antibacterial activity against Gram-positive pathogens, with MICs ranging from 0.06 to 2\u2005mg\/L. It demonstrated a rapid bactericidal effect against antibiotic-resistant pathogens, irrespective of their growth phase or tolerant state, and conferred an extended post-antibiotic effect. Significantly, LYSC98 displayed a low potential for resistance development. It targeted both bacterial cell wall and membrane, with in vitro membrane assays indicating selective damage to these structures and no observed harm to mammalian cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LYSC98\u2019s rapid bactericidal activity, selective disruption of bacteria without harming mammalian cells and low propensity for resistance development make it a novel promising candidate for combating chronic, clinically recalcitrant infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag036","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:42:38Z","timestamp":1768999358000},"source":"Crossref","is-referenced-by-count":0,"title":["LYSC98 as a novel vancomycin-derived agent effective against antibiotic-resistant pathogens in tolerant state"],"prefix":"10.1093","volume":"81","author":[{"given":"Xing","family":"Xia","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Shanghai Jiao Tong University , Shanghai 200240 ,","place":["China"]},{"name":"National Key Laboratory of Lead Druggability Research, China State Institute of Pharmaceutical Industry , Shanghai 200120 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Ge","sequence":"additional","affiliation":[{"name":"Research and Development Department, Shanghai Laiyi Center for Biopharmaceutical R&D , Shanghai 200240 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsheng","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Shanghai Jiao Tong University , Shanghai 200240 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuping","family":"Qian","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Shanghai Jiao Tong University , Shanghai 200240 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijie","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Shanghai Jiao Tong University , Shanghai 200240 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-6945","authenticated-orcid":false,"given":"Yu","family":"Yin","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Shanghai Jiao Tong University , Shanghai 200240 ,","place":["China"]},{"name":"National Key Laboratory of Lead Druggability Research, China State Institute of Pharmaceutical Industry , Shanghai 200120 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026021007451458300_dkag036-B1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1099\/jmm.0.030932-0","article-title":"Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies","volume":"60","author":"Fauvart","year":"2011","journal-title":"J Med Microbiol"},{"key":"2026021007451458300_dkag036-B2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41392-024-01866-5","article-title":"Bacterial persisters: molecular mechanisms and therapeutic development","volume":"9","author":"Niu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026021007451458300_dkag036-B3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.actbio.2022.11.055","article-title":"Hydrophobic modification improves the delivery of cell-penetrating peptides to eliminate intracellular pathogens in animals","volume":"157","author":"Tang","year":"2023","journal-title":"Acta Biomater"},{"key":"2026021007451458300_dkag036-B4","doi-asserted-by":"publisher","first-page":"1356540","DOI":"10.1155\/2019\/1356540","article-title":"Intracellular pathogens: host immunity and microbial persistence strategies","volume":"2019","author":"Thakur","year":"2019","journal-title":"J Immunol Res"},{"key":"2026021007451458300_dkag036-B5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aaj2191","article-title":"Antibiotic tolerance facilitates the evolution of resistance","volume":"355","author":"Levin-Reisman","year":"2017","journal-title":"Science"},{"key":"2026021007451458300_dkag036-B6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41579-022-00682-4","article-title":"Tolerance and resistance of microbial biofilms","volume":"20","author":"Ciofu","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"2026021007451458300_dkag036-B7","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1038\/s41467-022-30272-0","article-title":"Modulating the evolutionary trajectory of tolerance using antibiotics with different metabolic dependencies","volume":"13","author":"Zheng","year":"2022","journal-title":"Nat Commun"},{"key":"2026021007451458300_dkag036-B8","doi-asserted-by":"publisher","first-page":"106887","DOI":"10.1016\/j.ijantimicag.2023.106887","article-title":"Ceftolozane\/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: resistance mechanisms and synergistic activity","volume":"62","author":"Agyeman","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2026021007451458300_dkag036-B9","doi-asserted-by":"publisher","first-page":"615450","DOI":"10.3389\/fcimb.2020.615450","article-title":"Persistence of intracellular bacterial pathogens-with a focus on the metabolic perspective","volume":"10","author":"Eisenreich","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2026021007451458300_dkag036-B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: an emerging battleground in microbial communities","volume":"8","author":"Sharma","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"2026021007451458300_dkag036-B11","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/jac\/dkae241","article-title":"Comparative in vitro efficacy of antibiotics against the intracellular reservoir of Staphylococcus aureus","volume":"79","author":"Beadell","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026021007451458300_dkag036-B12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in glycopeptide antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infect Dis"},{"key":"2026021007451458300_dkag036-B13","doi-asserted-by":"publisher","first-page":"749685","DOI":"10.3389\/fmicb.2021.749685","article-title":"Biofilm-related infections in Gram-positive bacteria and the potential role of the long-acting agent dalbavancin","volume":"12","author":"Oliva","year":"2021","journal-title":"Front Microbiol"},{"key":"2026021007451458300_dkag036-B14","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1021\/acs.jmedchem.8b01093","article-title":"Battle against vancomycin-resistant bacteria: recent developments in chemical strategies","volume":"62","author":"Dhanda","year":"2019","journal-title":"J Med Chem"},{"key":"2026021007451458300_dkag036-B15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/IDR.S399150","article-title":"Pharmacokinetics and pharmacodynamics of a novel vancomycin derivative LYSC98 in a murine thigh infection model against Staphylococcus aureus","volume":"16","author":"He","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2026021007451458300_dkag036-B16","author":"CLSI"},{"key":"2026021007451458300_dkag036-B17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/jac\/dkp126","article-title":"Time\u2013kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium","volume":"63","author":"McKay","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"2026021007451458300_dkag036-B18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature12790","article-title":"Activated ClpP kills persisters and eradicates a chronic biofilm infection","volume":"503","author":"Conlon","year":"2013","journal-title":"Nature"},{"key":"2026021007451458300_dkag036-B19","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1099\/jmm.0.000749","article-title":"Can dalbavancin be used as a catheter lock solution?","volume":"67","author":"D\u00edaz-Ru\u00edz","year":"2018","journal-title":"J Med Microbiol"},{"key":"2026021007451458300_dkag036-B20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1074\/mcp.RA117.000461","article-title":"Quantitative proteomics of strong and weak biofilm formers of Enterococcus faecalis reveals novel regulators of biofilm formation","volume":"17","author":"Suriyanarayanan","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"2026021007451458300_dkag036-B21","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1128\/AEM.68.6.2950-2958.2002","article-title":"Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation","volume":"68","author":"Djordjevic","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"2026021007451458300_dkag036-B22","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.cell.2020.05.005","article-title":"A dual-mechanism antibiotic kills Gram-negative bacteria and avoids drug resistance","volume":"181","author":"Martin","year":"2020","journal-title":"Cell"},{"key":"2026021007451458300_dkag036-B23","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.1039\/D4TB00409D","article-title":"Intracellular infection-responsive macrophage-targeted nanoparticles for synergistic antibiotic immunotherapy of bacterial infection","volume":"12","author":"Dai","year":"2024","journal-title":"J Mater Chem B"},{"key":"2026021007451458300_dkag036-B24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/jac\/dki059","article-title":"Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages","volume":"55","author":"Seral","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2026021007451458300_dkag036-B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/jac\/47.4.391","article-title":"Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar","volume":"47","author":"Dom\u00ednguez","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"2026021007451458300_dkag036-B26","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1128\/AAC.37.10.2200","article-title":"A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations","volume":"37","author":"L\u00f6wdin","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"2026021007451458300_dkag036-B27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000239545","article-title":"Outer membrane proteins and elastase of Pseudomonas aeruginosa after the postantibiotic effect induced by amikacin","volume":"43","author":"Ho\u0161tack\u00e1","year":"1997","journal-title":"Chemotherapy"},{"key":"2026021007451458300_dkag036-B28","doi-asserted-by":"publisher","first-page":"eabo4736","DOI":"10.1126\/scitranslmed.abo4736","article-title":"Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity","volume":"16","author":"Groesen","year":"2024","journal-title":"Sci Transl Med"},{"key":"2026021007451458300_dkag036-B29","doi-asserted-by":"publisher","first-page":"12349","DOI":"10.1021\/ja1028843","article-title":"Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria","volume":"132","author":"Zhao","year":"2010","journal-title":"J Am Chem Soc"},{"key":"2026021007451458300_dkag036-B30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nchembio.1710","article-title":"Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane","volume":"11","author":"Hamamoto","year":"2015","journal-title":"Nat Chem Biol"},{"key":"2026021007451458300_dkag036-B31","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s11033-020-05361-2","article-title":"Biological barriers, and the influence of protein binding on the passage of drugs across them","volume":"47","author":"Wanat","year":"2020","journal-title":"Mol Biol Rep"},{"key":"2026021007451458300_dkag036-B32","doi-asserted-by":"publisher","first-page":"17658","DOI":"10.1038\/s41598-020-74834-y","article-title":"Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends","volume":"10","author":"Gajd\u00e1cs","year":"2020","journal-title":"Sci Rep"},{"key":"2026021007451458300_dkag036-B33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acsinfecdis.9b00484","article-title":"Correlating drug\u2013target residence time and post-antibiotic effect: insight into target vulnerability","volume":"6","author":"Davoodi","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2026021007451458300_dkag036-B34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1128\/AAC.00766-08","article-title":"Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro","volume":"53","author":"Belley","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026021007451458300_dkag036-B35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrmicro2474","article-title":"Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections","volume":"9","author":"Hurdle","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"2026021007451458300_dkag036-B36","doi-asserted-by":"publisher","first-page":"2306112","DOI":"10.1002\/advs.202306112","article-title":"A methylazanediyl bisacetamide derivative sensitizes Staphylococcus aureus persisters to a combination of gentamicin and daptomycin","volume":"11","author":"Heo","year":"2024","journal-title":"Adv Sci"},{"key":"2026021007451458300_dkag036-B37","doi-asserted-by":"publisher","first-page":"e1008431","DOI":"10.1371\/journal.ppat.1008431","article-title":"Bacteria under antibiotic attack: different strategies for evolutionary adaptation","volume":"16","author":"Windels","year":"2020","journal-title":"PLoS Pathog"},{"key":"2026021007451458300_dkag036-B38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/j.1552-4604.1982.tb02671.x","article-title":"Importance of protein binding for the interpretation of serum or plasma drug concentrations","volume":"22","author":"Greenblatt","year":"1982","journal-title":"J Clin Pharmacol"},{"key":"2026021007451458300_dkag036-B39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"2026021007451458300_dkag036-B40","doi-asserted-by":"publisher","first-page":"10185","DOI":"10.1021\/acs.jmedchem.1c00449","article-title":"Alkyl-aryl-vancomycins: multimodal glycopeptides with weak dependence on the bacterial metabolic state","volume":"64","author":"Sarkar","year":"2021","journal-title":"J Med Chem"},{"key":"2026021007451458300_dkag036-B41","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1016\/j.csbj.2023.11.031","article-title":"A promising antibiotic candidate, brevinin-1 analogue 5R, against drug-resistant bacteria, with insights into its membrane-targeting mechanism","volume":"21","author":"Zou","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"2026021007451458300_dkag036-B42","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1021\/acsomega.4c09804","article-title":"Probing antimicrobial activity and mechanism of action of a bile acid-derived antibiotic","volume":"10","author":"Tang","year":"2024","journal-title":"ACS Omega"},{"key":"2026021007451458300_dkag036-B43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12866-025-03973-x","article-title":"Fingolimod as a potent anti-Staphylococcus aureus: pH-dependent cell envelope damage and eradication of biofilms\/persisters","volume":"25","author":"Shang","year":"2025","journal-title":"BMC Microbiol"},{"key":"2026021007451458300_dkag036-B44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2017.12.004","article-title":"On the race to starvation: how do bacteria survive high doses of antibiotics?","volume":"68","author":"Tamer","year":"2017","journal-title":"Mol Cell"},{"key":"2026021007451458300_dkag036-B45","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.bbamem.2014.08.023","article-title":"Complementary biophysical tools to investigate lipid specificity in the interaction between bioactive molecules and the plasma membrane: a review","volume":"1838","author":"Deleu","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2026021007451458300_dkag036-B46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jgar.2015.12.007","article-title":"Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant Staphylococcus aureus infection","volume":"5","author":"Yarlagadda","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"2026021007451458300_dkag036-B47","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1073\/pnas.1904700116","article-title":"A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus","volume":"116","author":"Kim","year":"2019","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/3\/dkag036\/66840029\/dkag036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/3\/dkag036\/66840029\/dkag036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:45:19Z","timestamp":1770727519000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag036\/8471135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag036","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,2]]},"article-number":"dkag036"}}